ProductUpdated on 13 March 2025
Atophylline: a bioinspired skin care against atopic dermatitis (AD)
About
Based on an innovative concept of neutraligand, it acts selectively on chemokine CCL17 to block the vicious circle of AD.
Proven efficiency: Inhibits the chemokine CCL17 and not its receptor Inhibits genes involved in AD Stimulates synthesis of collagen, elastin and hyaluronic acid in normal cells.
Observations on volunteers: Reduces itchy skin, skin inflammation Increases hydration and skin barrier function Improves quality of life.
Attached files
Organisation
Similar opportunities
Service
Virtual screening tool for biological profiling
Quoc Tuan Do
Head of Chemoinformatics/Business development at Greenpharma
ORLEANS, France
Service
Medicinal Chemistry and synthesis on demand
- Others
- Consulting
- Testing & Analysis
- Research & Development
Quoc Tuan Do
Head of Chemoinformatics/Business development at Greenpharma
ORLEANS, France
Expertise
Christopher Holmes
Scientific Collaborator at Bern University of Applied Sciences (BFH)
Biel/Bienne, Switzerland